Señalización y Muerte Celular en Cáncer

A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors

Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score to Assess Survival in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Study of 550 Patients From Spain (REVAS Registry)

EDIL3 promotes epithelial-mesenchymal transition and paclitaxel resistance through its interaction with integrin alpha(V)beta(3)in cancer cells

Quantitative Analysis of Somatostatin and Dopamine Receptors Gene Expression Levels in Non-functioning Pituitary Tumors and Association with Clinical and Molecular Aggressiveness Features

Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation

p53 and FBXW7: Sometimes Two Guardians Are Worse than One

Active surveillance as a successful management strategy for patients with clinical stage I germ cell testicular cancer.

E-cadherin expression is associated with somatostatin analogue response in acromegaly.

Loss of MYBBP1A Induces Cancer Stem Cell Activity in Renal Cancer.

NOVEL intronic CAPN3 Roma mutation alters splicing causing RNA mediated decay.

SCF(FBXW7)-mediated degradation of p53 promotes cell recovery after UV-induced DNA damage.

Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly.

Bone marrow erythrocyte and neutrophil phagocytosis and cannibalism by neuroendocrine carcinoma.

Loss of Sarcomeric Scaffolding as a Common Baseline Histopathologic Lesion in Titin-Related Myopathies.

Obatoclax and Paclitaxel Synergistically Induced Apoptosis and Overcome Paclitaxel Resistance in Urothelial Cancer Cells.

Protocols for the Study of Taxanes Chemosensitivity in Prostate Cancer.

SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017).

Systematic Screening of Ubiquitin/p62 Aggregates in Cerebellar Cortex Expands the Neuropathological Phenotype of the C9orf72 Expansion Mutation.

Variably protease-sensitive prionopathy presenting within ALS/FTD spectrum

BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas.

Both p62/SQSTM1-HDAC6-dependent autophagy and the aggresome pathway mediate CDK1 degradation in human breast cancer

G1/S phase progression is regulated by PLK1 degradation through the CDK1/βTrCP axis.

HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients.

Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients.

Prognostic relevance of Src activation in stage II-III colon cancer

Resection of upper lip adenoid cystic carcinoma and reconstruction with reverse Yu flap: Report of three cases and a literature review.

Max inactivation in small-cell lung cancer disrupts the myc-swi/snf programs and is synthetic lethal with brg1.

PTTG1 expression modulates prostate cancer cell fate after paclitaxel treatment.

SCF ßTrCP controls the lysosome-mediated degradation of CDK1, whose accumulation correlates with tumor malignancy.

SCF(FBXW7α) modulates the intra-S-phase DNA-damage checkpoint by regulating Polo like kinase-1 stability.

A single mutation in securin chromosomal instability and enhances cell invasion

PTPL1 and PKCδ contribute to proapoptotic signalling in prostate cancer cells.

Prognostic value of CtIP/RBBP8 expression in breast cancer

Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients.